Atlas Trials

SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding

Clinical trial NCT04478019 · COMPLETED

Trial details

NCT number
NCT04478019
Sponsor
University of Wisconsin, Madison
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
COVID-19SARS-CoV 2
Start date
2020-07-07
Primary completion
2022-06-30
Enrollment
245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.